Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

C4 Therapeutics, Inc. - Common Stock (NQ:CCCC)

1.950 -0.080 (-3.94%)
Streaming Delayed Price Updated: 3:54 PM EST, Jan 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about C4 Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Forecasting The Future: 4 Analyst Projections For C4 Therapeutics ↗
 
Via Benzinga
News headline image
Why C4 Therapeutics Stock Crushed the Market on Monday ↗
A major recommendation change lit a big fire under the biotech as the trading week kicked off. 
Via The Motley Fool
News headline image
Here are the top movers in Monday's session. ↗
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
News headline image
Key Takeaways From C4 Therapeutics Analyst Ratings ↗
 
Via Benzinga
News headline image
Breaking Down C4 Therapeutics: 4 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Which stocks are moving on Monday? ↗
Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
CCCC Revenue Drops 46% ↗
Via The Motley Fool
News headline image
Analyst Expectations For C4 Therapeutics's Future ↗
 
Via Benzinga
News headline image
Which stocks are moving before the opening bell on Thursday? ↗
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
News headline image
AT&T To Rally More Than 33%? Here Are 10 Top Analyst Forecasts For Thursday ↗
 
Via Benzinga
News headline image
Methanex, Merck And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
CCCC Stock Earnings: C4 Therapeutics Beats EPS, Beats Revenue for Q2 2024 ↗
CCCC stock results show that C4 Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
CCCC Stock Earnings: C4 Therapeutics Misses EPS, Misses Revenue for Q1 2024 ↗
CCCC stock results show that C4 Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Capital One Financial To Acquire Discover, Joins SSR Mining And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
U.S. stock futures were lower this morning, with the Dow futures trading lower by around 50 points on Tuesday. 
Via Benzinga
Topics Stocks
News headline image
7 Exciting Stocks Poised for Explosive Growth in Key Sectors ↗
These stocks to buy for growth already have a strong growth story. If they reach their potential investors could see some dynamic returns. 
Via InvestorPlace
News headline image
What's Going On With C4 Therapeutics Stock? ↗
C4 Therapeutics, Inc. (NASDAQ: CCCC) shares are trading higher Friday, and the stock has gained more than 350% over the past five days. 
Via Benzinga
News headline image
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗
A look at five stocks that saw increased interest from Benzinga readers during the week. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Dow Jumps Over 200 Points; Federal Reserve Holds Interest Rates Steady ↗
U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision on Wednesday. The Dow traded up 0.58% to 36,789.77 while the NASDAQ rose 0.63% to 14,624.74.... 
Via Benzinga
Topics Economy Stocks
News headline image
Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance. The company said it now sees revenue of $690 million to $700... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Crude Oil Gains 1.5%; Blackboxstocks Shares Plummet ↗
U.S. stocks traded higher midway through trading, following the release of PPI data on Wednesday. The Dow traded up 0.06% to 36,598.24 while the NASDAQ rose 0.23% to 14,566.43. The S&P 500 also rose,... 
Via Benzinga
Topics Stocks
News headline image
US Stocks Mixed; Producer Prices Unchanged For November ↗
U.S. stocks traded mixed this morning, following the release of PPI data on Wednesday. Following the market opening Wednesday, the Dow traded down 0.05% to 36,561.18 while the NASDAQ rose 0.42% to... 
Via Benzinga
Topics Stocks
News headline image
C4 Therapeutics Stock Is Surging Wednesday: What's Going On? ↗
C4 Therapeutics Inc (NASDAQ: CCCC) shares are trading higher Wednesday after the company presented data from a Phase 1 trial for the p 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.